{"id":"ast-726-high-dose","_chembl":null,"_dailymed":null,"_scrapedAt":"2026-03-28T03:21:38.608Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_claudeStub":{"ts":1779123639,"model":"claude-sonnet-4-5-20250929"},"description":"AST-726 High dose is an investigational therapeutic being developed by Ariston Pharmaceuticals, Inc. currently in Phase 2 clinical trials. The molecular target, mechanism of action, and specific therapeutic indications have not been publicly disclosed at this time.","indications":{"approved":[{"status":"investigational","condition":null,"patientPopulation":null}]},"trialDetails":[{"nctId":"NCT00285402","phase":"PHASE2","title":"Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine","status":"UNKNOWN","sponsor":"Ariston Pharmaceuticals, Inc.","startDate":"2007-05","conditions":"Migraine, Migraine Headache, Migraine Disorders","enrollment":198}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":135054,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"AST-726 High dose","genericName":"AST-726 High dose","companyName":"Ariston Pharmaceuticals, Inc.","companyId":"ariston-pharmaceuticals-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":1,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":true,"score":2}}